Entera Bio Ltd (ENTX) insider trading

Every open-market stock purchase and sale by Entera Bio Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $121K over the last 12 months (6 buys).
  • Last insider buy: Geno J Germano (Director), $26K, 7 months ago.

Last 12 months: insiders bought $121K (6 buys) and sold $0 (0 sales). Last close $3.02 on Oct 22, 2026.

Recent ENTX insider trades

DateInsiderTradeValue
Aug 7, 2026Yonatan Malca (Director)Bought (not open market)—
Aug 7, 2026Haya Taitel (Director)Bought (not open market)—
Aug 7, 2026Sean Ellis (Director)Bought (not open market)—
Aug 7, 2026Sean Ellis (Director)Bought (not open market)—
Aug 7, 2026Hillel Galitzer (COO)Bought (not open market)—
Aug 7, 2026Dana Yaacov-Garbeli (CFO)Bought (not open market)—
Aug 7, 2026Gregory Burshtein (Officer)Bought (not open market)—
Aug 7, 2026Miranda Jayne Toledano (CEO)Bought (not open market)—
Aug 7, 2026Miranda Jayne Toledano (CEO)Bought (not open market)—
Aug 7, 2026Geno J Germano (Director)Bought (not open market)—
Aug 7, 2026Geno J Germano (Director)Bought (not open market)—
Aug 7, 2026Geno J Germano (Director)Bought (not open market)—
Jul 14, 2026Miranda Jayne Toledano (CEO)Bought (not open market)—
Jul 14, 2026Miranda Jayne Toledano (CEO)Bought (not open market)—
May 7, 2026Gregory Burshtein (Officer)Bought (not open market)—
May 7, 2026Dana Yaacov-Garbeli (CFO)Bought (not open market)—
May 7, 2026Hillel Galitzer (COO)Bought (not open market)—
Mar 9, 2026Geno J Germano (Director)Bought$26K
Mar 5, 2026Sean Ellis (Director)Bought$12.3K
Feb 10, 2026Geno J Germano (Director)Bought$29.8K
Feb 10, 2026Haya Taitel (Director)Bought$11.1K
Feb 9, 2026Sean Ellis (Director)Bought$22.3K
Jan 1, 2026Haya Taitel (Director)Bought (not open market)—
Jan 1, 2026Gerald M Ostrov (Director)Bought (not open market)—
Jan 1, 2026Gerald M Ostrov (Director)Bought (not open market)—

Who's trading ENTX

Get free alerts when an insider at Entera Bio Ltd files a new trade →